Metabolic-Fit / 100
Tablet Health review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Tablet Health advertises injectable semaglutide at $89.99 for the first month, then $139.99 a month, and tirzepatide at $129.99 first month, then $199.99. Three- and six-month prepaid packages have separate totals.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Tablet Health at a glance
- Semaglutide
- $139.99/mo after $89.99 first month
- Tirzepatide
- $199.99/mo after $129.99 first month
- Coverage
- Does not disclose a specific state list
- Brand-name
- Compounded only
How we scored Tablet Health
Every factor comes from Tablet Health's own published pricing, disclosures and oversight, and the six combine into the 40/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Tablet Health advertises injectable semaglutide at $89.99 for the first month, then $139.99 a month, and tirzepatide at $129.99 first month, then $199.99. Three- and six-month prepaid packages have separate totals.
Before you sign up
What Tablet Health's public site and signup page show before you hand over any details.
Worth knowing
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $139.99 | Publicly advertised plan; see note$139.99/mo after $89.99 first month. Confirm dose, supply period and renewal terms before payment. |
| Compounded tirzepatide | $199.99 | Publicly advertised plan; see note$199.99/mo after $129.99 first month. Confirm dose, supply period and renewal terms before payment. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Tablet Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- LegitScript Certified
- Opening physical pharmacy locations in NYC — an oversight signal beyond a pure DTC funnel
- No commitment, cancel anytime, stated plainly
The caveats
- Marketing copy elsewhere blurs 'FDA-registered labs' with FDA-approved medication — a real overstatement pattern
- Self-reported customer counts are inconsistent across the site (15,000+ vs. 10,000+)
- No specific state list published — its own FAQ leaves the question unanswered
- No postpartum, breastfeeding or PCOS-specific guidance found
The injectable renewal prices are higher than the introduction
Tablet Health advertises injectable semaglutide at $89.99 for the first month, then $139.99 per month, and injectable tirzepatide at $129.99 initially, then $199.99. The continuing figures are the relevant starting point for a recurring budget. A reader comparing only the introduction would overlook what the same advertised program costs after the first order.
The product pages also list three- and six-month prepaid packages: semaglutide at $349.99 or $749.99, and tirzepatide at $499.99 or $1,099.99. Those totals represent longer purchases, not a lower monthly payment available without the commitment. Ask what the selected term includes and how treatment changes are handled before choosing it on an equivalent-price calculation.
Oral advertising needs a separate product explanation
The homepage also promotes oral versions, but the current detailed price confirmation here concerns injectable plans. An oral product should not inherit an injection’s price, supply or evidence merely because both use the same molecule name. Ask which formulation is actually proposed and obtain its own complete quote and instructions.
Tablet operates a broader telehealth catalog that includes other wellness and sexual-health products. A low price on another card may describe a different service entirely. Anchor the comparison to the named medication and formulation, then establish the clinical review, supplies, shipping and ongoing contact included in the specific weight-loss plan.
A facility claim is not approval of the prescription
Tablet displays an FDA compounding disclaimer while other marketing refers to clinically proven GLP-1 medications and FDA-registered labs. Those phrases can blur different questions. Registration of a facility is not approval of a finished compounded drug, and evidence for a named branded medication does not automatically establish results for a different formulation.
Ask the prescriber to identify the actual product and dispensing pharmacy rather than relying on the broad marketing description. The available information does not independently establish the full set of pharmacy partners. Do not infer a particular pharmacy assignment from an outside directory or assume that every prescription is filled through the same partner.
State access is not answered by the FAQ heading
Tablet’s public FAQ has a question about shipping states without a substantive answer beneath it. That leaves the service footprint unresolved for a prospective patient. Confirm that an appropriately licensed clinician and the selected pharmacy can serve the intended location before treating the displayed price as an available option.
The site also displays certification language and differing customer counts. These are seller-presented trust signals, not a substitute for identifying the assigned medical professional and checking the actual certification record. The more practical questions concern who reviews the assessment, whether a live appointment is available and how medication concerns reach the clinical team afterward.
Cancellation language needs its operational terms
Tablet describes no commitment and cancellation at any time. Ask what that means for the chosen monthly or prepaid plan: the next charge date, deadline to prevent pharmacy preparation and treatment of a purchase already fulfilled. The ability to stop future service does not establish a refund for unused medication or unused months of a package.
The public content does not describe a dedicated postpartum, breastfeeding or PCOS pathway. Tablet may be relevant to someone wanting a lower introductory injection payment followed by a disclosed renewal amount, but the broader service needs confirmation. Decide using the actual second-month total, identified clinician and pharmacy, state access and written stopping terms rather than the first-month card or the largest prepaid discount alone.
The bottom line for mothers
Best for: Mothers who specifically want a needle-free oral GLP-1 option and are comfortable calling ahead to confirm their state.
Alternatives to Tablet Health
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Strut Health80
Metabolic-Fit / 100
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
- Visit yourEra76
Metabolic-Fit / 100
A low-entry, all-in compounded program with both molecules, one price at every dose and a clean cancel-anytime policy — appealing, though the 'from' price isn't explained and the outcome claims are unverified marketing.
Providers like Tablet Health
Keep comparing Tablet Health
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Tablet Health, answered
- How much does Tablet Health cost?
- Tablet Health advertises injectable semaglutide at $89.99 for the first month, then $139.99 a month, and tirzepatide at $129.99 first month, then $199.99. Three- and six-month prepaid packages have separate totals.
- Does Tablet Health serve my state?
- It doesn't say. The site's own FAQ asks 'What states do you ship to?' and leaves the answer blank — call and confirm before you sign up.
- Is Tablet Health's GLP-1 medication FDA-approved?
- No — like most compounded programs, it isn't. Some of Tablet Health's own marketing copy ('Clinically-proven,' 'FDA-registered labs') blurs an FDA-registered facility with an FDA-approved drug. Read that as ordinary compounding-industry overstatement, not a claim the medication itself is approved.
Pricing, states and verification reflect Tablet Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.